MedDataX Logo

Pelvic Osteotomy in Bladder Exstrophy

NCT ID: NCT06717386

Last Updated: 2024-12-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

10 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-12-02

Study Completion Date

2026-02-02

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study focuses on the surgical treatment of bladder exstrophy, a congenital condition where the bladder is located outside the body. It examines the use of modified diagonal pelvic osteotomy combined with an external fixator as a treatment approach. This method aims to improve pelvic support and facilitate proper bladder reconstruction. The study likely evaluates the outcomes, complications, and overall effectiveness of this surgical technique in enhancing patient quality of life and functional results. Key findings may include insights into recovery times, rates of successful bladder closure, and potential long-term benefits for patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bladder Exstrophy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

bladder epithpidius complex

diagonal pelvic osteotomy in bladder exstrophy

Group Type OTHER

diagonal pelvic osteotomy

Intervention Type PROCEDURE

supraacetabular pelvic osteotomy in oblique shape

bladder exstrophy

horizontal pelvic osteotomy

Group Type OTHER

diagonal pelvic osteotomy

Intervention Type PROCEDURE

supraacetabular pelvic osteotomy in oblique shape

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

diagonal pelvic osteotomy

supraacetabular pelvic osteotomy in oblique shape

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. age: all cases of delayed exstrophy repaior
2. sex : both gender
3. children who received no operative treatment befor

Exclusion Criteria

1. previous pelvic surgery
2. sever comorbidities
Minimum Eligible Age

6 Months

Maximum Eligible Age

6 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sohag University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ali Abdelaal Bakheet

assistant lecturer

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Sohag University

Sohag, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Ali abdel aal Bakheet, assistant lecturer

Role: CONTACT

Phone: 02001010505552

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Ali Bakheet, assistant lecturer

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Soh-Med-24-11-1MD

Identifier Type: -

Identifier Source: org_study_id